Form 4 for XPO XPO, Inc.
Accepted 2023-03-14 00:00:00 ET · period of report 2023-03-10 · accession 0001166003-23-000034 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-14 | 2023-03-10 | XPO | Brown Christopher Michael | CAO | M - OptEx | $0.00 | +702 | 11.3K | +7% | $0 |
| D | 2023-03-14 | 2023-03-10 | XPO | Brown Christopher Michael | CAO | F - Tax | $34.65 | -326 | 11.0K | -3% | -$11.3K |
| D | 2023-03-14 | 2023-03-10 | XPO | Brown Christopher Michael | CAO | M - OptEx | $0.00 | -702 | 1,403 | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.001 per share | 2023-03-10 | M | A | 702 | $0.00 | 11,336 | D | — | — | |
| 2 | Common | Common Stock, par value $0.001 per share | 2023-03-10 | F | D | 326 | $34.65 | 11,010 | D | — | — | (F1) No shares were sold by the Reporting Person. These shares were withheld by the Issuer to fund tax liability attributable to the vesting and settlement of the Restricted Stock Units ("RSUs") reported on this Form 4. These RSUs vested and were settled as originally scheduled, and there were no related discretionary transactions or open market sales. |
| 3 | Derivative | Restricted Stock Unit | 2023-03-10 | M | D | 702 | $0.00 | 1,403 | D | — · — to — | 702 Common Stock, par value $0.001 per share | (F2) Each RSU represents a contingent right to receive, upon settlement, either (i) one share of Common Stock or (ii) a cash payment equal to the fair market value of one share of Common Stock. (F3) These RSUs vest in four equal annual installments on March 10, 2022, March 10, 2023, March 10, 2024 and March 10, 2025, generally subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date. |